US Court Allows Patent for Marijuana Formulation
A federal court ruling last week set a precedent for property rights to cannabis products in the quickly growing marijuana industry.
U.S. District Judge William Martinez, an Obama appointee who presides in Colorado, ruled that cannabinoid formulations can be considered the unique handiwork of their developers and not naturally occurring substances.
The ruling appears to be a first for the marijuana industry at a time it is being legalized by states nationwide and gaining investors, according to intellectual property attorneys.
A recent report from Arcview Market Research and its research partner BDS Analytics showed spending on legal cannabis worldwide is expected to reach $57 billion by 2027. Cannabis is the active ingredient that makes the marijuana plant a drug.
Adult-use for the recreational market will make up 67 percent of the spending while medical uses take up the rest, according to Arcview Market Research.
The biggest growth is expected in North America, rising from $9.2 billion in 2017 to $47.3 billion a decade later, the report says.
Courts have avoided patent disputes over marijuana previously because only in recent years have states started legalizing it. It remains a Schedule 1 illegal drug under federal law, punishable as a felony offense for possession or sale.
Colorado, where the court ruling was issued, was among the first states to legalize both medicinal and recreational use of marijuana.
The 10th Circuit ruling allows the medical marijuana firm United Cannabis to retain its patent on a liquid cannabinoid formulation that was challenged by a competing company.
The competitor, Pure Hemp Collective, argued that it could sell the same formulation without United Cannabis’ permission because it is a naturally occurring substance.
Only products that represent the unique work of the inventors can win enforceable patents under U.S. law.
Judge Martinez agreed with United Cannabis that its formulation was not “an unpatentable law of nature, a natural phenomenon or an abstract idea.”
He wrote that even if it were “theoretically possible” that cannabinoids could occur in nature in liquid form, the patent specifies threshold concentrations of those cannabinoids.
The patent covers several liquid cannabinoid formulations, including ones that require at least 95 percent of the total cannabinoids be CBD, a non-toxic component of marijuana that relieves chronic pain and other ailments.
“Pure Hemp nowhere claims that these precise concentrations, or anything close to them, occur in liquid form in nature,” Martinez wrote.
Pure Hemp accused United Cannabis in its court filings of trying to monopolize the market for liquid CBD products by incorrectly classifying chemicals found naturally in cannabis plants as a unique product.
“There is no difference between the CBD that can be found naturally within the cannabis plant, and the CBD that is the subject [of claims in the patent],” Pure Hemp wrote in a November court filing.
The case is United Cannabis Corp. v. Pure Hemp Collective Inc. The case number 18-cv-01922, in U.S. District Court for the District of Colorado.
In The News
NEW YORK — Former vice-presidential candidate Sarah Palin was diagnosed with COVID-19 this weekend, which delayed her defamation lawsuit against... Read More
NEW YORK — Former vice-presidential candidate Sarah Palin was diagnosed with COVID-19 this weekend, which delayed her defamation lawsuit against The New York Times that was scheduled for a trial beginning Monday. Palin reported her illness to Judge Jed Rakoff of the U.S. District Court in... Read More
WASHINGTON — Two coaches from the Washington Nationals baseball team are adding to the lawsuits spun off from mandates by... Read More
WASHINGTON — Two coaches from the Washington Nationals baseball team are adding to the lawsuits spun off from mandates by the federal government and private employers requiring employees to get vaccinated against COVID-19. The federal mandate announced by President Joe Biden last fall takes effect next... Read More
PHOENIX — Attorneys General from 23 states signed on to an amicus brief that challenges an Arizona law prohibiting abortions... Read More
PHOENIX — Attorneys General from 23 states signed on to an amicus brief that challenges an Arizona law prohibiting abortions sought because of fetal abnormalities. The coalition contends in their brief that the preservation of women’s reproductive autonomy can and should occur while simultaneously dismissing discriminatory... Read More
NEW YORK (AP) — Former President Donald Trump sued New York Attorney General Letitia James on Monday, resorting to a familiar... Read More
NEW YORK (AP) — Former President Donald Trump sued New York Attorney General Letitia James on Monday, resorting to a familiar but seldom successful strategy as he seeks to end a yearslong civil investigation into his business practices that he alleges is purely political. In the lawsuit, filed... Read More
FAUQUIER COUNTY, Va. — A Virginia judge ruled last week that a hospital has no authority to block a family’s... Read More
FAUQUIER COUNTY, Va. — A Virginia judge ruled last week that a hospital has no authority to block a family’s choice to be treated for COVID-19 with the controversial drug ivermectin. The drug is not approved by the Food and Drug Administration to treat COVID-19. The... Read More
NEW YORK — New York’s Attorney General Letitia James has subpoenaed former president Donald J. Trump to appear in a... Read More
NEW YORK — New York’s Attorney General Letitia James has subpoenaed former president Donald J. Trump to appear in a deposition next month to answer allegations regarding the Trump organization’s involvement in improperly valuing real estate assets. The request falls on top of a mountainous pile... Read More